Driver mutation-specific clinical and genomic correlates differ between primary and secondary myelofibrosis

Am J Hematol. 2019 Dec;94(12):E314-E317. doi: 10.1002/ajh.25625. Epub 2019 Sep 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Abnormal Karyotype
  • Aged
  • Aged, 80 and over
  • Blood Cell Count
  • Calreticulin / genetics*
  • Female
  • Follow-Up Studies
  • Genomics*
  • Humans
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Polycythemia Vera / complications
  • Primary Myelofibrosis / blood
  • Primary Myelofibrosis / genetics*
  • Prognosis
  • Receptors, Thrombopoietin / genetics*
  • Survival Analysis
  • Thrombocythemia, Essential / complications

Substances

  • CALR protein, human
  • Calreticulin
  • Receptors, Thrombopoietin
  • MPL protein, human
  • JAK2 protein, human
  • Janus Kinase 2